Neutral
Agilent Technologies Inc. reported a Q1 2026 earnings miss by one cent, with adjusted EPS at $1.36 and revenue of $1.80 billion, slightly below analys...
Neutral
Agilent Technologies Inc. reported a Q1 2026 earnings per share of $1.36, narrowly missing the consensus estimate of $1.37, while revenue rose 7% year...
Neutral
Agilent Technologies is facing market volatility and recent legal challenges, specifically a patent ruling discussed in *Agilent Technologies, Inc. v....
Agilent Technologies (A) has been actively expanding its growth story through new biopharma collaborations and the launch of its 16850 Series portable...
Bullish
Agilent Technologies and Veeda Lifesciences have partnered to create a joint Center of Excellence (CoE) in Bengaluru to enhance analytical and bioanal...
The article asks which stock, Agilent Technologies or Danaher, has more upside. However, the provided content is largely navigational and boilerplate ...
Bullish
Agilent Technologies has expanded its collaboration with India's Centre for Cellular and Molecular Platforms (C-CAMP) to increase access to advanced a...
Neutral
Agilent Technologies reported Q1 2026 EPS of $1.36, missing estimates by $0.01, with revenue at $1.80 billion, slightly below expectations. The compan...
Neutral
Crossmark Global Holdings Inc. increased its stake in Agilent Technologies, Inc. by 39.6% in the fourth quarter, purchasing an additional 9,615 shares...
Neutral
Agilent Technologies (A) stock is being evaluated for its current pricing, showing mixed returns recently with a 2.7% gain over the last week but a 14...
Neutral
Mitsubishi UFJ Asset Management Co. Ltd. has increased its stake in Agilent Technologies, Inc. (NYSE:A) by 4.3% in Q4, now owning 599,581 shares value...
Neutral
Robeco Schweiz AG decreased its stake in Agilent Technologies by 9.9% in the fourth quarter, now holding 1,049,058 shares valued at approximately $142...
Agilent Technologies (A) has received FDA approval for its PD-L1 IHC 22C3 pharmDx test as the sole companion diagnostic for specific esophageal and ga...
Bullish
Agilent Technologies Inc. reported strong second-quarter fiscal 2026 results, surpassing both revenue and EPS forecasts due to robust demand in life s...
Agilent Technologies Inc. (NYSE: A) will release its financial results for the second quarter of fiscal year 2026 after the stock market closes on Wed...
Neutral
The Google Discover 2026 Core Update is significantly changing how retail investors access information on stocks like Agilent Technologies Inc. (US008...
Neutral
Agilent Technologies Inc (A) shares dropped 5.0% to $114.42, which is 20.3% below its estimated fair value of $143.49, indicating it is modestly under...
Bullish
This article compares Agilent Technologies (A) and Danaher (DHR), concluding that Agilent Technologies is a better investment. The analysis highlights...
Neutral
Agilent Technologies' chromatographs are crucial for drug testing and research, offering high-resolution separation essential for breakthroughs in pha...
Bullish
Agilent Technologies Inc (A) shares rose 3.1% to $121.87 and are considered "Modestly Undervalued" according to GuruFocus' GF Value™, which is estimat...